SEC Form 4 · accession 0001144204-15-010746
SANGAMO THERAPEUTICS, INC · SGMO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Peter Kolchinsky
Other
Period of report
Dec 12, 2013
Accepted (ET)
Feb 18, 2015 · 6:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001001233
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 12, 2013 | P | 9,600 | $12.0907 | A | 4,037,962 | D | |
| Common StockF1 | Dec 13, 2013 | P | 5,040 | $12.0875 | A | 4,043,002 | D | |
| Common StockF1 | Jan 9, 2014 | S | 27,483 | $18.4678 | D | 4,015,519 | D | |
| Common StockF1,F2 | Jan 9, 2014 | S | 44,957 | $18.28 | D | 3,970,562 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported securities are owned by RA Capital Healthcare Fund, L.P. (the "Fund"). RA Capital Management, LLC (the "Adviser") is the general partner of the Fund, and Peter Kolchinsky is the sole manager of the Adviser. The Adviser and Mr. Kolchinsky disclaim beneficial ownership of the reported securities in reliance on Rule 16a-1(a)(1)(v) and (vii), respectively, and therefore disclaim any obligation to report ownership of the reported securities other than on behalf of the Fund. The filing of this Form 4 shall not be construed as an admission that either the Adviser or Mr. Kolchinsky is or was, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owner of any of the securities reported herein. The number of shares reported in Column 5 of Table I reflects the number of shares beneficially owned by the Fund as of the time of the last transaction reported herein.
- F2On December 11, 2013, the Fund became a beneficial owner of more than ten percent of the outstanding shares the issuer's common stock and therefore became subject to Section 16 of the Securities Exchange Act of 1934. On January 9, 2014, the Fund ceased to be a beneficial owner of more than ten percent of the outstanding shares of the issuer's common stock and ceased to be subject to Section 16.